# Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers

> **NCT02434939** · PHASE4 · COMPLETED · sponsor: **Makerere University** · enrollment: 240 (actual)

## Conditions studied

- Sickle Cell Crisis
- Acute Pain

## Interventions

- **DRUG:** Low dose ketamine
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT02434939
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2016-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434939, "Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02434939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*